Concentration-effect relationships for the drug of abuse γ-hydroxybutyric acid

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 3, 2010, Pages 764-771

  Felmlee, Melanie A ^a   Roiko, Samuel A ^a   Morse, Bridget L ^a   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; GLUTAMIC ACID;

ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CORPUS STRIATUM; DETOXIFICATION; DIALYSATE; DOSE RESPONSE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; EXTRACELLULAR FLUID; FRONTAL CORTEX; HIPPOCAMPUS; HYPNOSIS; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; SEDATION; SLEEP TIME; TANDEM MASS SPECTROMETRY;

ANESTHETICS, INTRAVENOUS; ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; GLUTAMATES; HYPNOTICS AND SEDATIVES; INDICATORS AND REAGENTS; MALE; MASS SPECTROMETRY; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; SODIUM OXYBATE; TIME FACTORS;

EID: 77952386385     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.165381     Document Type: Article

References (44)

1. Arena C and Fung HL (1980) Absorption of sodium gamma-hydroxybutyrate and its prodrug gamma-butyrolactone: relationship between in vitro transport and in vivo absorption. J Pharm Sci 69:356-358.
2. Banerjee PK and Snead OC 3rd (1995) Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. J Pharmacol Exp Ther 273:1534-1543.
3. Bouw MR and Hammarlund-Udenaes M (1998) Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method. Pharm Res 15:1673-1679.
4. Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, et al. (2001) Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428:315-321.
5. Carter LP, Chen W, Coop A, Koek W, and France CP (2006) Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538:85-93.
6. Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, and France CP (2003) The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668-674.
7. Carter LP, Koek W, and France CP (2009) Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther 121:100-114.
8. de Lange EC and Danhof M (2002) Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 41:691-703.
9. de Lange EC, de Boer AG, and Breimer DD (2000) Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Deliv Rev 45:125-148.
10. Ferrara SD, Zotti S, Tedeschi L, Frison G, Castagna F, Gallimberti L, Gessa GL, and Palatini P (1992) Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol 34:231-235.
11. Fung HL, Haas E, Raybon J, Xu J, and Fung SM (2004) Liquid chromatographic-mass spectrometric determination of endogenous gamma-hydroxybutyrate concentrations in rat brain regions and plasma. J Chromatogr B Analyt Technol Biomed Life Sci 807:287-291.
12. Gallimberti L, Spella MR, Soncini CA, and Gessa GL (2000) Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20:257-262.
13. Gobaille S, Hechler V, Andriamampandry C, Kemmel V, and Maitre M (1999) gamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo. J Pharmacol Exp Ther 290:303-309.
14. Gold BI and Roth RH (1977) Kinetics of in vivo conversion of gamma-[3H]aminobutyric acid to gamma-[3H]hydroxybutyric acid by rat brain. J Neurochem 28:1069-1073.
15. Goodwin AK, Brown PR, Jansen EE, Jakobs C, Gibson KM, and Weerts EM (2009) Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology (Berl) 204:465-476.
16. Hechler V, Ratomponirina C, and Maitre M (1997) gamma-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide. J Pharmacol Exp Ther 281:753-760.
17. Jensen K and Mody I (2001) L-type Ca2+ channel-mediated short-term plasticity of GABAergic synapses. Nat Neurosci 4:975-976.
18. Kapadia R, Böhlke M, and Maher TJ (2007) Detection of gamma-hydroxybutyrate in striatal microdialysates following peripheral 1,4-butanediol administration in rats. Life Sci 80:1046-1050.
19. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, et al. (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722-2730.
20. Koek W, Chen W, Mercer SL, Coop A, and France CP (2006) Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose. J Pharmacol Exp Ther 317:409-417.
21. Koek W and France CP (2008) Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists. Psychopharmacology (Berl) 199:191-198.
22. Kusuhara H and Sugiyama Y (2004) Efflux transport systems for organic anions and cations at the blood-CSF barrier. Adv Drug Deliv Rev 56:1741-1763.
23. Lettieri JT and Fung HL (1979) Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J Pharmacol Exp Ther 208:7-11.
24. Lin JH (2008) CSF as a surrogate for assessing CNS exposure: an industrial perspective. Curr Drug Metab 9:46-59.
25. Liu X, Smith BJ, Chen C, Callegari E, Becker SL, Chen X, Cianfrogna J, Doran AC, Doran SD, Gibbs JP, et al. (2006) Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration. Drug Metab Dispos 34:1443-1447.
26. Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361.
27. Mamelak M (2009) Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 89:193-219.
28. Mamelak M, Scharf MB, and Woods M (1986) Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9:285-289.
29. Mason PE and Kerns WP 2nd (2002) Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 9:730-739.
30. Mathivet P, Bernasconi R, De Barry J, Marescaux C, and Bittiger H (1997) Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol 321:67-75.
31. Morris ME, Hu K, and Wang Q (2005) Renal clearance of gamma-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy. J Pharmacol Exp Ther 313:1194-1202.
32. Okun MS, Boothby LA, Bartfield RB, and Doering PL (2001) GHB: an important pharmacologic and clinical update. J Pharm Pharm Sci 4:167-175.
33. Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, Gallimberti L, Gessa GL, and Ferrara SD (1993) Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 45:353-356.
34. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, New York.
35. Raybon JJ and Boje KM (2007) Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine. J Pharmacol Exp Ther 320:1252-1260.
36. Smith MA, Gergans SR, and Lyle MA (2006) The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam. Eur J Pharmacol 552:83-89.
37. Snead OC 3rd (1978) Gamma hydroxybutyrate in the monkey. I. Electroencephalographic, behavioral, and pharmacokinetic studies. Neurology 28:636-642.
38. Snead OC 3rd (1990) gamma-Hydroxybutyric acid-induced seizures bear no relation to core temperature. Epilepsia 31:253-258.
39. Snead OC 3rd (1991) The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology 30:161-167.
40. Snead OC 3rd, Yu RK, and Huttenlocher PR (1976) Gamma hydroxybutyrate. Correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioral effects. Neurology 26:51-56.
41. Tedeschi L, Carai MA, Frison G, Favretto D, Colombo G, Ferrara SD, and Gessa GL (2003) Endogenous gamma-hydroxybutyric acid is in the rat, mouse and human gastrointestinal tract. Life Sci 72:2481-2488.
42. Van Sassenbroeck DK, De Paepe P, Belpaire FM, Rosseel MT, Martens P, Boon PA, and Buylaert WA (2001) Relationship between gamma-hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat. J Pharm Pharmacol 53:1687-1696.
43. Wang Q, Wang X, and Morris ME (2008a) Effects of L-lactate and D-mannitol on gamma-hydroxybutyrate toxicokinetics and toxicodynamics in rats. Drug Metab Dispos 36:2244-2251.
44. Wang X, Wang Q, and Morris ME (2008b) Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters. AAPS J 10:47-55.